Related Experiment Video
Updated: Nov 20, 2025
08:27
Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
11.2K
Exosomes: A Key Piece in Asthmatic Inflammation.
José A Cañas1,2, José M Rodrigo-Muñoz1,2, Marta Gil-Martínez1
1Immunoallergy Laboratory, Immunology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Avenida Reyes Católicos, 2, 28040 Madrid, Spain.
International Journal of Molecular Sciences
|January 22, 2021
Summary
Extracellular vesicles, particularly exosomes, play a key role in asthma pathogenesis by transporting inflammatory molecules. Understanding these exosomes offers new insights into this common respiratory disease.
Area of Science:
- Immunology
- Cell Biology
- Respiratory Medicine
Background:
- Asthma is a chronic airway inflammatory disease involving multiple cell types and cytokines.
- Extracellular vesicles (EVs), including exosomes, mediate intercellular communication and inflammation.
- Exosomes transport proteins, lipids, and microRNAs (miRNAs), influencing physiological and pathological processes.
Purpose of the Study:
- To review current knowledge on the role of exosomes in asthma.
- To explore exosomes from various cell types and biofluids in the context of asthma.
Main Methods:
- Literature review of recent research on exosomes and asthma.
- Analysis of exosome composition and function in asthma pathogenesis.
Main Results:
- Exosomes are implicated in the inflammatory pathways of asthma.
- Exosomes from different sources (cells, biofluids) carry specific molecular cargo relevant to asthma.
- Exosome detection in biofluids may provide diagnostic or prognostic information.
Conclusions:
- Exosomes are significant mediators in asthma.
- Further research into exosome-based diagnostics and therapeutics for asthma is warranted.
Related Concept Videos
01:36Overview of Exosomes
3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
01:26Asthma-II: Pathophysiology and Classification
3.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
01:29Asthma-I: Introduction
3.0K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
01:20Asthma: Pathogenesis and Management
974
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
974
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.5K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.5K